ABC | Volume 112, Nº5, May 2019

Viewpoint Souza et al. Resident macrophages and heart rate Arq Bras Cardiol. 2019; 112(5):588-591 This is an open-access article distributed under the terms of the Creative Commons Attribution License 12. Held C, White HD, Stewart RAH, Budaj A, Cannon CP, Hochman JS, et al. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. J AmHeart Assoc. 2017;6(10):pii-e005077. 13. Ridker PM, Libby P, MacFadyen JG, Thuren T, Ballantyne C, Fonseca F, et al. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Eur Heart J. 2018;39(38):3499–507. 14. Ridker PM, Lüscher TF. Anti-inflammatory therapies for cardiovascular disease. Eur Heart J. 2014;35(27):1782–91. 15. Cruz JS, Machado FS, Ropert C, Roman-Campos D. Molecular mechanisms ofcardiacelectromechanicalremodelingduringChagasdisease:RoleofTNF and TGF- β . Trends Cardiovasc Med. 2017;27(2):81–91. 16. MerxMW,WeberC.Sepsisandtheheart.Circulation.2007;116(7):793–802. 17. Wang HE, Moore JX, Donnelly JP, Levitan EB, Safford MM. Risk of Acute Coronary Heart Disease After Sepsis Hospitalization in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort. Clin Infect Dis. 2017;65(1):29–36. 18. Zannad F. Rising incidence of heart failure demands action. Lancet. 2018;391(10120):518–9. 19. Patel B, Bansal SS, Ismahil MA, Hamid T, Rokosh G, Mack M, et al. CCR2+ Monocyte-Derived Infiltrating Macrophages Are Required for Adverse Cardiac RemodelingDuringPressureOverload.JACCBasicTranslSci.2018;3(2):230-44. 20. Zupančič E, Fayad ZA, Mulder WJM. Cardiovascular Immunotherapy and the Role of Imaging. Arterioscler Thromb Vasc Biol. 2017;37(11):e167–71. 21. Martini E, Stirparo GG, Kallikourdis M. Immunotherapy for cardiovascular disease. J Leukoc Biol. 2018;103(3):493–500. 591